Hematopoietic Recovery Data
. | ANC (>0.5 × 109/L) . | WBC (>1.0 × 109/L) . | Platelets . | Last Day of Transfusions . | Febrile Days (>38°C) . | ||
---|---|---|---|---|---|---|---|
(>20 × 109/L) . | (>50 × 109/L) . | RBC . | Platelets . | ||||
Treated group | |||||||
G-CSF(+) | 11 | 11 | 22 | 31 | 11 | 27 | 4 |
n = 30 | (8-20) | (8-20) | (7-101) | (13-123) | (0-81) | (6-91) | (0-15) |
Control | |||||||
G-CSF(−) | 12 | 11 | 16 | 26 | 10 | 13 | 4 |
n = 28 | (9-49) | (9-29) | (6-45) | (11-100) | (2-69) | (5-82) | (0-11) |
P value | |||||||
t-test | .034 | .180 | .020 | .265 | .231 | .037 | .577 |
U-test | .021 | .199 | .086 | .455 | .68 | .077 | .716 |
. | ANC (>0.5 × 109/L) . | WBC (>1.0 × 109/L) . | Platelets . | Last Day of Transfusions . | Febrile Days (>38°C) . | ||
---|---|---|---|---|---|---|---|
(>20 × 109/L) . | (>50 × 109/L) . | RBC . | Platelets . | ||||
Treated group | |||||||
G-CSF(+) | 11 | 11 | 22 | 31 | 11 | 27 | 4 |
n = 30 | (8-20) | (8-20) | (7-101) | (13-123) | (0-81) | (6-91) | (0-15) |
Control | |||||||
G-CSF(−) | 12 | 11 | 16 | 26 | 10 | 13 | 4 |
n = 28 | (9-49) | (9-29) | (6-45) | (11-100) | (2-69) | (5-82) | (0-11) |
P value | |||||||
t-test | .034 | .180 | .020 | .265 | .231 | .037 | .577 |
U-test | .021 | .199 | .086 | .455 | .68 | .077 | .716 |
Figures represent median value/(range). Boldface type means the statistical significance (P < .05).